株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

世界のヒアルロン酸 (HA) 市場:2017年〜2021年

Global Hyaluronic Acid Market 2017-2021

発行 TechNavio (Infiniti Research Ltd.) 商品コード 563426
出版日 ページ情報 英文 86 Pages
即納可能
価格
本日の銀行送金レート: 1USD=111.43円で換算しております。
Back to Top
世界のヒアルロン酸 (HA) 市場:2017年〜2021年 Global Hyaluronic Acid Market 2017-2021
出版日: 2017年09月28日 ページ情報: 英文 86 Pages
概要

世界のヒアルロン酸市場は、2017年から2021年の予測期間中、CAGRが8.7%成長する見込みとなっております。

当レポートでは、世界のヒアルロン酸市場について調査分析を行い、市場概要、市場動向、市場規模などについて考察するとともに、製品別、用途別、地域別に市場を分析、ベンダーの状況などについて包括的に分析し、まとめています。

第1章 エグゼクティブサマリー

第2章 調査の範囲

第3章 調査方法

第4章 イントロダクション

第5章 市場の状況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 市場セグメンテーション:製品別

  • 世界のヒアルロン酸市場:製品別
  • 5回投与サイクル
  • 3回投与サイクル
  • 単回投与サイクル

第7章 市場セグメンテーション:用途別

  • 世界のヒアルロン酸市場:用途別
  • 皮膚フィラー
  • 変形性関節炎
  • 眼科手術
  • 膀胱尿管逆流

第8章 地域別セグメンテーション

  • 世界のヒアルロン酸市場:地域別
  • 北米
  • 欧州
  • アジア太平洋地域
  • 世界のその他の諸国

第9章 決定の枠組み

第10章 促進因子と課題

第11章 市場動向

  • コスト効率の高い原料の生産
  • HAの代替品

第12章 ベンダーの状況

  • 競合シナリオ
  • 主な市場ベンダー
  • その他のベンダー

第13章 主要ベンダー分析

  • ALLERGAN
  • Anika Therapeutics
  • Sanofi
  • SEIKAGAKU
  • Zimmer Biomet

第14章 付録

図表
  • Exhibit 01: Synonyms of HA
  • Exhibit 02: Synthesis of HA (process flow)
  • Exhibit 03: Segmentation of global HA market
  • Exhibit 04: Global HA market 2016 and 2021 ($ millions)
  • Exhibit 05: Market forecast: Global HA market 2016-2021
  • Exhibit 06: Five forces analysis
  • Exhibit 07: Global HA market by product type 2016 (% share of revenue)
  • Exhibit 08: Global HA market by product type 2021 (% share of revenue)
  • Exhibit 09: Global five-injection cycle HA market 2016 and 2021 ($ millions)
  • Exhibit 10: Market forecast: Global five-injection cycle HA market 2016-2021
  • Exhibit 11: Global three-injection cycle HA market 2016 and 2021 ($ millions)
  • Exhibit 12: Market forecast: Global three-injection cycle HA market 2016-2021
  • Exhibit 13: Global single-injection cycle HA market 2016 and 2021 ($ millions)
  • Exhibit 14: Market forecast: Global single-injection cycle HA market 2016-2021
  • Exhibit 15: Global HA market by application 2016 (% share of revenue)
  • Exhibit 16: Global HA market by application 2021 (% share of revenue)
  • Exhibit 17: Global HA market in the dermal fillers segment 2016 and 2021 ($ millions)
  • Exhibit 18: Market forecast: Global HA market in the dermal fillers segment 2016-2021
  • Exhibit 19: Global HA market in the osteoarthritis segment 2016 and 2021 ($ millions)
  • Exhibit 20: Market forecast: Global HA market in the osteoarthritis segment 2016-2021
  • Exhibit 21: Global HA market in the ophthalmic surgery segment 2016 and 2021 ($ millions)
  • Exhibit 22: Market forecast: Global HA market in the ophthalmic surgery segment 2016-2021
  • Exhibit 23: Global HA market in the VUR segment 2016 and 2021 ($ millions)
  • Exhibit 24: Market forecast: Global HA market in the VUR segment 2016-2021
  • Exhibit 25: Global HA market by geography 2016 (% share of revenue)
  • Exhibit 26: Global HA market by geography 2021 (% share of revenue)
  • Exhibit 27: HA market in North America 2016 and 2021 ($ millions)
  • Exhibit 28: Market forecast: HA market in North America 2016-2021
  • Exhibit 29: HA market in Europe 2016 and 2021 ($ millions)
  • Exhibit 30: Market forecast: HA market in Europe 2016-2021
  • Exhibit 31: HA market in APAC 2016 and 2021 ($ millions)
  • Exhibit 32: Market forecast: HA market in APAC 2016-2021
  • Exhibit 33: HA market in ROW 2016 and 2021 ($ millions)
  • Exhibit 34: Market forecast: HA market in ROW 2016-2021
  • Exhibit 35: Population of age 65 years and above (% of total population) (2005-2016)
  • Exhibit 36: Applications of HA in dermal fillers
  • Exhibit 37: Side effects of HA
  • Exhibit 38: Key market vendors
  • Exhibit 39: ALLERGAN: Business segmentation by revenue 2016 (% share)
  • Exhibit 40: Anika Therapeutics: Business segmentation by revenue 2016 (% share)
  • Exhibit 41: Anika Therapeutics: Geographical segmentation by revenue 2016 (% share)
  • Exhibit 42: Sanofi: Business segmentation by revenue 2016 (% share)
  • Exhibit 43: Sanofi: Geographical segmentation by revenue 2016 (% share)
  • Exhibit 44: SEIKAGAKU: Business segmentation by revenue 2016 (% share)
  • Exhibit 45: SEIKAGAKU: Geographical segmentation by revenue 2016 (% share)
  • Exhibit 46: Zimmer Biomet: Business segmentation by revenue 2016 (% share)
  • Exhibit 47: Zimmer Biomet: Geographical segmentation by revenue 2016 (% share)
目次
Product Code: IRTNTR14567

About Hyaluronic Acid

HA is an anionic and non-sulfated glycosaminoglycan, which is present in human body especially in the joints in the form of fluids; it acts as a lubricant, thereby providing a cushioning effect. HA is primarily used in medical and cosmetic applications such as dermal fillers, osteoarthritis, ophthalmic surgery, and VUR. In addition, it helps in the healing of wounds. The rising demand for cosmetics and non-surgical procedures is expected to drive the growth of the HA market.

Technavio's analysts forecast the global hyaluronic acid market to grow at a CAGR of 8.7% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global hyaluronic acid market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • APAC
  • Europe
  • North America
  • ROW

Technavio's report, Global Hyaluronic Acid Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ALLERGAN
  • Anika Therapeutics
  • Sanofi
  • SEIKAGAKU
  • Zimmer Biomet

Other Prominent Vendors

  • Contipro
  • Ferring
  • Fidia Farmaceutici
  • Galderma
  • Hyalogic
  • HYALTECH
  • Lifecore Biomedical
  • Maruha Nichiro
  • Meiji Holdings
  • Merz Pharma
  • Rayner
  • Shiseido
  • TRB CHEMEDICA INTERNATIONAL
  • Valeant

Market driver

  • Increased ailments among the growing aging population
  • For a full, detailed list, view our report

Market challenge

  • Intense competition leading to reduced ASP
  • For a full, detailed list, view our report

Market trend

  • Production of HA with cost-effective raw materials
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction

  • Market outline

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Global HA market by product type
  • Global five-injection cycle HA market
  • Global three-injection cycle HA market
  • Global single-injection cycle HA market

PART 07: Market segmentation by application

  • Global HA market by application
  • Global HA market in the dermal fillers segment
  • Global HA market in the osteoarthritis segment
  • Global HA market in the ophthalmic surgery segment
  • Global HA market in the VUR segment

PART 08: Geographical segmentation

  • Global HA market by geography
  • HA market in North America
  • HA market in Europe
  • HA market in APAC
  • HA market in ROW

PART 09: Decision framework

PART 10: Drivers and challenges

  • Market drivers
  • Market challenges

PART 11: Market trends

  • Production of HA with cost-effective raw materials
  • Rising substitutes for HA

PART 12: Vendor landscape

  • Competitive scenario
  • Key market vendors
  • Other prominent vendors

PART 13: Key vendor analysis

  • ALLERGAN
  • Anika Therapeutics
  • Sanofi
  • SEIKAGAKU
  • Zimmer Biomet

PART 14: Appendix

  • List of abbreviations
Back to Top